Author

G. Mattiuzzo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:proteomics· 1

Frequent Co-Authors

Y. Takeuchi· 3 shared E. M. Bentley· 2 shared A. Karatt-Vellatt· 1 shared A. Kinna· 1 shared A. M. Munis· 1 shared C. Allen· 1 shared C. Tebbutt· 1 shared D. Matthews· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Y. Takeuchi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Distantly related hepaciviruses share common entry factor, Claudin-1

K. Toon, M. D. Kalemera, M. Palor, N. J. ROSE, Y. Takeuchi, J. Grove, G. Mattiuzzo

This study identifies Claudin-1 as a shared entry factor for HCV and GBV-B, showing distinct mechanisms for each virus.

bioRxiv · Aug 10, 2022 · PreprintMicrobiology

Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants

M. Ferrari, L. Mekkaoui, F. T. Ilca, Z. Akbar, R. Bughda, K. Lamb, K. Ward, F. Parekh, R. Karattil, C. Allen, P. Wu, V. Baldan, G. Mattiuzzo, E. M. Bentley, Y. Takeuchi, , S. Onuoha

The paper characterizes a novel ACE2-based therapeutic that effectively neutralizes SARS-CoV-2 variants and demonstrates antibody-like properties and manufacturability.

bioRxiv · Mar 17, 2021Immunology

Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergence

G. Bullen, J. D. Galson, P. Villar, L. Moreels, L. Ledsgaard, G. Mattiuzzo, G. Hall, E. M. Bentley, E. W. Masters, D. Tang, S. Millett, D. Tongue, R. Brown, I. Diamantopoulos, K. Parthiban, , A. Karatt-Vellatt

The paper identifies potent neutralising antibodies from early COVID-19 patient samples and shows high convergence in antibody sequences across studies.

bioRxiv · Dec 29, 2020 · PreprintImmunology

Characterisation of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins

A. M. Munis, M. Tijani, M. Hassall, G. Mattiuzzo, M. K. Collins, Y. Takeuchi

This paper characterizes two monoclonal antibodies against VSVind.G and their cross-reactivity with other vesiculovirus G proteins, identifying binding epitopes and neutralization mechanisms.

bioRxiv · May 25, 2018Microbiology